MediGene partnered with the Johns Hopkins to develop MediGene's adeno-associated virus-like particle (AAVLP) vaccine technology for cancers caused by HPV

Medigene AG

Germany / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

The Johns Hopkins University

U.S. / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced